ClearNote Health's enhanced Avantect Pancreatic Cancer Test features industry-leading detection sensitivity and specificity ...
A blood sample does not have an obvious odor to a person in a lab coat. But to an electronic nose, it can carry a chemical signature that points toward disease.
Nav, a machine learning-based natural language processing (NLP) model analyzes more than 10,000 magnetic resonance imaging (MRI) and computed tomography (CT) scan reports weekly across Northwell's ...
Using machine learning, an electronic nose can "smell" early signs of ovarian cancer in the blood. The method is precise and, ...
Researchers have developed an electronic nose that can “smell” early signs of ovarian cancer in the blood. The method is precise and could eventually be used to find many different cancers.
Morning Overview on MSN
New blood markers may spot early-onset pancreatic cancer before symptoms hit
Pancreatic ductal adenocarcinoma is one of the most lethal cancers, in large part because it usually stays hidden until it ...
Startup SpotitEarly is pioneering an innovative early cancer screening test based on breath samples and powered by artificial intelligence and the strong scent detection of trained dogs. SpotitEarly ...
As healthcare systems worldwide grapple with rising cancer rates, chronic diseases and limited clinical resources, ...
The ‘MYCN’ gene creates a specific nook that turns healthy liver cells into cancer. Detecting MYCN gene early could help identify and reduce liver cancer risk.
ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced the launch of its enhanced Avantect(R) Pancreatic Cancer Test, which delivers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results